The Febrile Neutropenia Market is on the cusp of significant transformation, driven by a multitude of factors that are reshaping its landscape. With a projected market size of USD 20.15 billion by 2035, the sector is poised for persistent growth, influenced by substantial advancements in treatment options and increased awareness of febrile neutropenia among healthcare providers. The anticipated...